NCT05530200 2022-09-07PRaG Regimens Rechallenge for Patients With Resistance to PD1/PD-L1 Inhibitors in Refractory Advanced Solid Tumors.Second Affiliated Hospital of Soochow UniversityPhase 2 Unknown56 enrolled